Maximum Daily Magnesium Glycinate Intake

Standard Upper Limits for Healthy Adults

The Institute of Medicine recommends a Tolerable Upper Intake Level of 350 mg/day of elemental magnesium from supplemental sources alone for adults, with the American College of Nutrition suggesting that this limit should be adjusted based on individual needs and health status 1
The recommended daily allowance is 320 mg/day for women and 420 mg/day for men, which includes both dietary and supplemental sources, as suggested by the National Institutes of Health 1

Magnesium supplementation is absolutely contraindicated when creatinine clearance falls below 20 mL/min due to life-threatening hypermagnesemia risk, as stated by the American Society of Nephrology 1
The kidneys are responsible for magnesium excretion, and impaired renal function dramatically increases the risk of magnesium accumulation, with the National Kidney Foundation recommending close monitoring of serum magnesium levels in patients with renal impairment 1

For patients with creatinine clearance >60 mL/min, standard dosing up to 350 mg/day elemental magnesium from supplements is generally safe, as recommended by the European Renal Association 1
For patients with creatinine clearance 30-60 mL/min, reduced doses with close monitoring are recommended, with the American College of Physicians suggesting that doses be adjusted based on individual patient needs 1
For patients with creatinine clearance 20-30 mL/min, magnesium supplementation should be avoided unless in life-threatening emergency situations with intensive monitoring, as stated by the International Society of Nephrology 1
For patients with creatinine clearance <20 mL/min, magnesium supplementation is absolutely contraindicated, with the National Institutes of Health recommending alternative treatments for these patients 1

Patients on warfarin require careful monitoring when starting magnesium supplementation, as renal impairment increases bleeding risk when combined with warfarin, with the American Heart Association recommending regular checks of renal function and serum magnesium levels 1
Patients on SGLT2 inhibitors, GLP-1 receptor agonists, or insulin require careful monitoring when starting magnesium supplementation, as magnesium can affect glucose metabolism, with the American Diabetes Association recommending regular monitoring of blood glucose levels 3, 4
Patients on ACE inhibitors, ARBs, or aldosterone antagonists require enhanced monitoring due to potential effects on electrolyte balance, with the American College of Cardiology recommending regular checks of serum magnesium, potassium, and renal function 1

Initial assessment should include checking baseline renal function, measuring serum magnesium, potassium, and calcium, and reviewing all current medications for interactions, as recommended by the National Institutes of Health 1
Early follow-up should include rechecking serum magnesium level, assessing for gastrointestinal side effects, and monitoring renal function if baseline eGFR <60 mL/min, with the American Society of Nephrology recommending regular monitoring of these parameters 1
Maintenance monitoring should include checking magnesium levels every 3 months once on stable dosing, with more frequent monitoring for patients with short bowel syndrome, high GI losses, or on medications affecting magnesium, as recommended by the European Society of Parenteral and Enteral Nutrition 1

The most common side effects are diarrhea, abdominal distension, and gastrointestinal intolerance, which can be minimized by dividing doses throughout the day, taking magnesium at night, and using liquid or dissolvable formulations, as recommended by the American Gastroenterological Association 1, 3
If diarrhea occurs, the dose should be reduced by 50% and tolerance reassessed, with the National Institutes of Health recommending alternative treatments if symptoms persist 1

For patients with QTc >500 ms, magnesium should be repleted to >2 mg/dL regardless of baseline level as an anti-torsadogenic countermeasure, with the American College of Cardiology recommending close medical supervision 1
For patients on continuous renal replacement therapy, dialysis solutions containing magnesium should be used to prevent hypomagnesemia rather than oral supplementation, as recommended by the International Society of Nephrology 1
For patients with short bowel syndrome, higher doses of magnesium are required due to significant losses, with the European Society of Parenteral and Enteral Nutrition recommending rehydration to correct secondary hyperaldosteronism before magnesium supplementation 1